Table 1.

Patient characteristics

Patients (n)	101
Age median (range)	69 years (43–87)
PSA median (range)	11.113 ng/ml (0.970–178.200)
IR(n)	49
HR(n)	52
GS
GS 6	4
GS 7a	30
GS 7b	37
GS 8	9
GS 9	21
Clinical T-stage
T1c	41
T2a	9
T2b	7
T2c	39
T3a	2
T3b	3

N, number; IR, intermediate-risk group; HR, high-risk group; GS, Gleason score; GS 7a corresponds to GS 3 + 4; GS 7b corresponds to GS 4 + 3